CHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve.
| dc.book.title | Therapies for Retinal Degeneration: Targeting Common Processes | |
| dc.contributor.author | Bravo Osuna, Irene | |
| dc.contributor.author | Andrés Guerrero, Vanesa | |
| dc.contributor.author | Molina Martínez, Irene Teresa | |
| dc.contributor.author | Herrero Vanrell, María Del Rocío | |
| dc.contributor.editor | De la Rosa, Enrique | |
| dc.contributor.editor | Cotter, Thomas | |
| dc.date.accessioned | 2024-01-19T12:14:50Z | |
| dc.date.available | 2024-01-19T12:14:50Z | |
| dc.date.issued | 2018 | |
| dc.description | Título: RSC DRUG DISCOVERY SERIES ISSN relacionados: 2041-3211 País: United Kingdom Ámbito: CIENCIAS MÉDICAS Y DE LA SALUD Campo académico: FARMACOLOGÍA Y FARMACIA Indizada en: Scopus (ELSEVIER), EMBASE (ELSEVIER) Métricas en: SJR. SCImago Journal & Country Rank, Scopus Sources | |
| dc.description.abstract | Diseases affecting the retina and the optic nerve are the major causes of irreversible blindness in the elderly population. Succesful therapy of these pathologies requires frequent administration of the active molecule close to the retinal target site. Intraocular drug delivery systems (IDDS) are emerging therapeutic tools in the treatment of diseases affecting the posterior segment, as they are able to provide effective concentrations of the drug for a long period, thus avoiding successive injections. Depending on their size, IDDS are classified in implants, microsystems and nanosystems. This chapter covers a general description of the IDDS useful for the treatment of diseases affecting retinal structures. © The Royal Society of Chemistry 2019. | |
| dc.description.department | Depto. de Farmacia Galénica y Tecnología Alimentaria | |
| dc.description.faculty | Fac. de Farmacia | |
| dc.description.refereed | TRUE | |
| dc.description.sponsorship | Ministerio de Ciencia, Innovación y Universidades (España) | |
| dc.description.sponsorship | Ministerio de Economía, Comercio y Empresa (España) | |
| dc.description.sponsorship | Instituto de Salud Carlos III | |
| dc.description.status | pub | |
| dc.identifier.citation | Bravo-Osuna I., Andrés-Guerrero V., Molina-Martínez I.T., Herrero-Vanrell R. CHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve (2019) RSC Drug Discovery Series, 2019-January (66), pp. 164 - 178. DOI: 10.1039/9781788013666-00164. EDITORS: de la Rosa E.J., Cotter T.G. UBLISHER: Royal Society of Chemistry. ISSN: 20413203. | |
| dc.identifier.doi | 10.1039/9781788013666-00164 | |
| dc.identifier.isbn | 978-1-78262-949-8 | |
| dc.identifier.isbn | 978-1-78801-366-6 | |
| dc.identifier.isbn | 978-1-78801-536-3 | |
| dc.identifier.officialurl | https://doi.org/10.1039/9781788013666 | |
| dc.identifier.relatedurl | https://books.rsc.org/books/edited-volume/702/Therapies-for-Retinal-Degeneration-Targeting | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14352/94041 | |
| dc.language.iso | eng | |
| dc.page.final | 178 | |
| dc.page.initial | 164 | |
| dc.page.total | 14 | |
| dc.publication.place | Reino Unido | |
| dc.publisher | Royal Society of Chemistry | |
| dc.relation.ispartofseries | Drug Discovery | |
| dc.relation.projectID | info:eu-repo/grantAgreement/PI17/00079 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/PI17/00466 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MAT2013-43217R | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/MAT2017-83858-C2-2-R/ES/MICROTECNOLOGIAS DE APLICACION BIOMEDICA EN EL TRATAMIENTO DE LA NEURODEGENERACION EN EL GLAUCOMA/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/RD16/0008 | |
| dc.rights.accessRights | metadata only access | |
| dc.subject.keyword | Drug delivery system | |
| dc.subject.keyword | Intraocular drug administration | |
| dc.subject.keyword | Microtechnology | |
| dc.subject.keyword | Nanotechnology | |
| dc.subject.keyword | Optic nerve | |
| dc.subject.keyword | Neurodegenerative disease | |
| dc.subject.keyword | Pharmaceutical technology | |
| dc.subject.keyword | Ophthalmology | |
| dc.subject.ucm | Ciencias Biomédicas | |
| dc.subject.ucm | Tecnología farmaceútica | |
| dc.subject.ucm | Oftalmología | |
| dc.subject.ucm | Farmacia | |
| dc.subject.unesco | 24 Ciencias de la Vida | |
| dc.title | CHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve. | |
| dc.type | book part | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 491381a5-fc5a-4cd5-a0b0-9b6cfdae6706 | |
| relation.isAuthorOfPublication | 14096cb3-8372-40d2-8fe1-79d0c4c1ddd7 | |
| relation.isAuthorOfPublication | 43cca2c8-2da7-45dd-bce6-4b70a86a3877 | |
| relation.isAuthorOfPublication | e19672b5-d6f7-400a-b591-b903bc396955 | |
| relation.isAuthorOfPublication.latestForDiscovery | 491381a5-fc5a-4cd5-a0b0-9b6cfdae6706 |